Author

J. E. Krol

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metagenomics· 1 Approach:statistical model· 1

Frequent Co-Authors

G. D. Ehrlich· 2 shared A. Ahmed· 1 shared B. Sen· 1 shared D. C. Hall· 1 shared H.-F. Ji· 1 shared J. Lapides· 1 shared J. P. Cahill· 1 shared J. P. Earl· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

G. D. Ehrlich

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Evidence for the Existence of a Bacterial Etiology for Alzheimers Disease and for a Temporal-Spatial Development of a Pathogenic Microbiome in the Brain

Y. Mone, J. P. Earl, J. E. Krol, A. Ahmed, B. Sen, G. D. Ehrlich, J. Lapides

The paper identifies bacterial communities in Alzheimer's Disease and control brains, finding a complex microbiome dynamics associated with AD pathogenesis.

bioRxiv · Aug 28, 2022Microbiology

The Development of a Pipeline for the Identification and Validation of Small-Molecule RelA Inhibitors for Use as Anti-biofilm Drugs

D. C. Hall, J. E. Krol, J. P. Cahill, H.-F. Ji, G. D. Ehrlich

This paper develops a hybrid computational and experimental pipeline to identify and validate small-molecule RelA inhibitors as anti-biofilm drugs.

bioRxiv · Jul 27, 2020Microbiology